A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. (Q48832455)
Jump to navigation
Jump to search
scientific article published in October 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. |
scientific article published in October 1994 |
Statements
1 reference
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. (English)
1 reference
Chouinard G
1 reference
Saxena BM
1 reference
Nair NP
1 reference
Kutcher SP
1 reference
Bakish D
1 reference
Bradwejn J
1 reference
Kennedy SH
1 reference
Sharma V
1 reference
Remick RA
1 reference
Kukha-Mohamad SA
1 reference
1 October 1994
1 reference
1 reference
32
1 reference
2
1 reference
105-114
1 reference
Identifiers
1 reference
1 reference